NEW YORK, Dec. 20 - Genomic Solutions said on Thursday that it has completed its cash-and-stock acquisition of Cartesian Technologies, a deal it says will bolster its high-throughput screening and "strengthen its position as a global provider of comprehensive DNA analysis and drug discovery solutions."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.